TY - JOUR T1 - Treating active rheumatoid arthritis with Janus kinase inhibitors JO - Lancet UR - http://eprints.whiterose.ac.uk/118272/ PY - 2017/06/16 AU - Scott DL AU - Stevenson MD ED - DO - DOI: 10.1016/S0140-6736(17)31659-8 Y2 - 2025/05/21 ER -